SANTEN OBTAINS US FDA ACCEPTANCE OF PMA APPLICATION FOR DE-128

HIGHLIGHTS

• Santen Pharmaceutical Co., Ltd. has submitted the Premarket Approval (PMA) application for DE-128 (MicroShunt) for review.
• US FDA has accepted the application from Santen.
• DE-128 is an investigational surgical glaucoma implant.